@article {723,
	title = {Identification and therapeutic rescue of autophagosome and glutamate receptor defects in C9ORF72 and sporadic ALS neurons.},
	journal = {JCI Insight},
	volume = {5},
	year = {2019},
	month = {2019 07 16},
	abstract = {<p>Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease with diverse etiologies. Therefore, the identification of common disease mechanisms and therapeutics targeting these mechanisms could dramatically improve clinical outcomes. To this end, we developed induced motor neuron (iMN) models from C9ORF72 and sporadic ALS (sALS) patients to identify targets that are effective against these types of cases, which together comprise ~90\% of patients. We find that iMNs from C9ORF72 and several sporadic ALS patients share two common defects - impaired autophagosome formation and the aberrant accumulation of glutamate receptors. Moreover, we show that an anticoagulation-deficient form of activated protein C, 3K3A-APC, rescues these defects in both C9ORF72 and sporadic ALS iMNs. As a result, 3K3A-APC treatment lowers C9ORF72 dipeptide repeat protein (DPR) levels, restores nuclear TDP-43 localization, and rescues the survival of both C9ORF72 and sporadic ALS iMNs. Importantly, 3K3A-APC also lowers glutamate receptor levels and rescues proteostasis in vivo in C9ORF72 gain- and loss-of-function mouse models. Thus, motor neurons from C9ORF72 and at least a subset of sporadic ALS patients share common, early defects in autophagosome formation and glutamate receptor homeostasis and a single therapeutic approach may be efficacious against these disease processes.</p>},
	issn = {2379-3708},
	doi = {10.1172/jci.insight.127736},
	author = {Shi, Yingxiao and Hung, Shu-Ting and Rocha, Gabriel and Lin, Shaoyu and Linares, Gabriel R and Staats, Kim A and Seah, Carina and Wang, Yaoming and Chickering, Michael and Lai, Jesse and Sugawara, Tohru and Sagare, Abhay P and Zlokovic, Berislav V and Ichida, Justin K}
}
